Jonas Ekblom

Stay informed with Jonas Ekblom’s coverage and analysis for Fortune.

  • NEW YORK, NEW YORK – APRIL 19: Charli XCX attends Mugler H&M Global Launch Event on April 19, 2023 in New York City. (Photo by Arturo Holmes/Getty Images)Finance

    H&M blames missed profit targets on a gloomy summer and growing competition from rival Shein

    By Jonas Ekblom and Bloomberg
  • People visit an exhibition containing private banknotes in Sweden.Finance

    Why going cashless has turned Sweden from one of the safest countries into a high-crime nation

    By Niclas Rolander, Jonas Ekblom, and others
  • Satya Nadella, CEO of Microsoft.Tech

    Microsoft announces plans to invest $3.2 billion in Swedish AI—its largest-ever infrastructure bet in the Nordic country

    By Jonas Ekblom and Bloomberg
  • people seen walking on a busy streetRetail

    H&M’s spring clean is paying off as profit beats estimates under new CEO’s turnaround plan

    By Jonas Ekblom and Bloomberg
  • Elon Musk reacts during the UK Artificial Intelligence (AI) Safety Summit at Bletchley Park, in central England.Tech

    Elon Musk’s Tesla union troubles in Scandinavia are escalating rapidly as union boss says his ‘feudal lord’ attitude is ‘just wrong’

    By Jonas Ekblom, Stefan Nicola, and others
  • Elon Musk, chief executive officer of Tesla Inc., during a fireside discussion on artificial intelligence risks with Rishi Sunak, UK prime minister, in London, UK, on Thursday, Nov. 2, 2023. Sunak convened this week’s AI summit in an effort to position the UK at the forefront of global efforts to stave off the risks presented by the rapidly-advancing technology, which in the prime minister’s own words, could extend as far as human extinction. Photographer: Tolga Akmen/EPA/Bloomberg via Getty ImagesTech

    Tesla scores a major victory in its ‘insane’ war against Sweden’s labor unions and government over a ‘very serious’ threat to its business

    By Jonas Ekblom and Bloomberg
  • Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company’s headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Carsten Snejbjerg/Bloomberg via Getty ImagesHealth

    Weight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company

    By Jonas Ekblom, Marthe Fourcade, and others